您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告
健康网讯:
Market Report on Antiarrhythic Drugs in China Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd Published: Format: Hardcopy and Adobe PDF Price: US$2,700 Contact: Mr. Bian chenghua Ms. Wu huifang Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68012929-2008 E-mail: bianch@healthoo.com wuhf@healthoo.com http://www.healthoo.com 1 Categories of antiarrhythic drugs and epidemiology 2 Market scale and growth trend 2.1 Theoretical market scale 2.2 Growth trend in the past few years 2.3 Top 10 breeds ranked by sales value 2.4 Comparison of domestic and import brand 2.5 Analysis about DDDs and daily cost of drug 3 Market analysis of 4 categories drugs 3.1 Natrium Ion Channel Blocker 3.2 β-receptor blocker 3.3 Action potential duration prolongation agent 3.4 Calcium Ion Channel Blocker 4 Market analysis of key breeds 4.1 Natrium Ion Channel Blocker Ⅰa class: Quinidine, Procainamide, Acecainide, Disopyramide, etc. Ⅰb class: lidocaine, Phenytoin, Mexiletine, Aprindine, Tocainide, Moracizine, etc Ⅰc class: Encainide, Flecainide, Propafenone, etc 4.2 β-receptor blocker Propranolol, Nadolol, Timolol, Metoprolol, Atenolol 4.3 Action potential duration prolongation agent Amiodarone, britylium, Sotalol, Dofetilide, Ibutilide, Acecainide, Bunaftine, Cibenzoline 4.4 Calcium Ion Channel Blocker Verapamil, Tiapamil, Gallopamil, Diltiazem, Nifedipine 4.5 Others
|